Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;267(1):162-167.
doi: 10.1007/s00415-019-09567-8. Epub 2019 Oct 8.

Serum Neurofilament Light Chain Is a Discriminative Biomarker Between Frontotemporal Lobar Degeneration and Primary Psychiatric Disorders

Affiliations
Free PMC article

Serum Neurofilament Light Chain Is a Discriminative Biomarker Between Frontotemporal Lobar Degeneration and Primary Psychiatric Disorders

Kasper Katisko et al. J Neurol. .
Free PMC article

Abstract

Due to the significant clinical overlap between frontotemporal lobar degeneration (FTLD) spectrum disorders and late-onset primary psychiatric disorders (PPD), diagnostic biomarkers reflecting the different underlying pathophysiologies are urgently needed. Thus far, elevated cerebrospinal fluid (CSF) levels of neurofilament light chain (NfL) have been reported in various neurological conditions. Furthermore, recent advancements in ultrasensitive analytical methods (e.g., single molecule array, Simoa) have enabled sensitive and less invasive NfL detection also from blood samples. In this study, we evaluated the potential of serum NfL (sNfL) as a diagnostic tool between FTLD and PPD. We analyzed sNfL levels with Simoa from 125 participants including patients from FTLD (n = 91) and PPD (n = 34) spectra. Our results show that sNfL levels are higher in the FTLD group compared to the PPD group as well as in separate clinical subtypes of FTLD compared to different psychiatric manifestations (i.e., mood or psychotic disorders). At single-subject level, discrimination between FTLD and PPD was possible with 80% sensitivity and 85% specificity (AUC = 0.850, 95% CI 0.776-0.923), and between behavioral variant frontotemporal dementia (bvFTD) and PPD with 79% sensitivity and 85% specificity (AUC = 0.830, 95% CI 0.732-0.908). These findings highlight the potential of sNfL as a discriminating biomarker for FTLD over PPD in patients with wide-ranging behavioral, psychiatric and cognitive symptoms.

Keywords: Biomarker; Frontotemporal dementia; Frontotemporal lobar degeneration; Neurofilament light (NfL); Psychiatric disorders; sNfL.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
SNfL concentrations representing each case in each group with group medians and interquartile ranges (IQR). Statistical comparison was performed with general linear model (each of the comparisons made separately) with age as a covariate. sNfL serum neurofilament light, FTLD frontotemporal lobar degeneration, bvFTD behavioral variant frontotemporal dementia, PPA primary progressive aphasia, FTLD-MND frontotemporal lobar degeneration with motor neuron disease, PPD primary psychiatric disorders

Similar articles

See all similar articles

References

    1. Galimberti D, Dell’Osso B, Altamura AC, Scarpini E. Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biol Psychiatry. 2015;78:684–692. doi: 10.1016/j.biopsych.2015.03.028. - DOI - PubMed
    1. Solje E, Aaltokallio H, Koivumaa-Honkanen H, et al. The phenotype of the C9ORF72 expansion carriers according to revised criteria for bvFTD. PLoS ONE. 2015 doi: 10.1371/journal.pone.0131817. - DOI - PMC - PubMed
    1. Woolley JD, Khan BK, Murthy NK, et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72:126–133. doi: 10.4088/JCP.10m06382oli. - DOI - PMC - PubMed
    1. Khalil M, Teunissen CE, Otto M, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577–589. doi: 10.1038/s41582-018-0058-z. - DOI - PubMed
    1. Andreasson U, Blennow K, Zetterberg H. Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders. Alzheimer’s Dement Diagn Assess Dis Monit. 2016;25(3):98–102. doi: 10.1016/j.dadm.2016.05.005. - DOI - PMC - PubMed

LinkOut - more resources

Feedback